SMS Pharmaceuticals Limited (BOM:532815)
249.95
-3.95 (-1.56%)
At close: Jun 5, 2025
SMS Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, SMS Pharmaceuticals had annual revenue of 7.89B INR with 11.24% growth. SMS Pharmaceuticals had revenue of 2.48B in the quarter ending March 31, 2025, with 0.98% growth.
Revenue
7.89B
Revenue Growth
+11.24%
P/S Ratio
2.75
Revenue / Employee
6.59M
Employees
1,197
Market Cap
21.73B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 7.89B | 797.09M | 11.24% |
Mar 31, 2024 | 7.09B | 1.87B | 35.86% |
Mar 31, 2023 | 5.22B | 21.77M | 0.42% |
Mar 31, 2022 | 5.20B | -433.03M | -7.69% |
Mar 31, 2021 | 5.63B | 1.49B | 35.93% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |
SMS Pharmaceuticals News
- 5 weeks ago - SMS Pharmaceuticals’ Visakhapatnam facility receives WHO prequalification - Business Upturn